Practice variability and efficacy of clonazepam, lorazepam, and midazolam in status epilepticus: A multicenter comparison

Epilepsia

Volumn 56, Issue 8, 2015, Pages 1275-1285

  Alvarez, Vincent ^a,b   Lee, Jong Woo ^a   Drislane, Frank W ^a   Westover, M Brandon ^a   Novy, Jan ^c   Dworetzky, Barbara A ^a   Rossetti, Andrea O ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Valais Hospitals   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Benzodiazepines; Coma; Critical care; Epilepsy; Neurologic emergency

Indexed keywords

CLONAZEPAM; LORAZEPAM; MIDAZOLAM; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE;

ADULT; ARTICLE; DRUG EFFICACY; EPILEPTIC STATE; FEMALE; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REFRACTORY PERIOD; RISK ASSESSMENT; TREATMENT OUTCOME; AGED; CLINICAL PRACTICE; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; MIDDLE AGED; PROSPECTIVE STUDY; STATUS EPILEPTICUS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; BENZODIAZEPINES; CLONAZEPAM; COHORT STUDIES; FEMALE; HUMANS; LORAZEPAM; MALE; MIDAZOLAM; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES; STATUS EPILEPTICUS; TREATMENT OUTCOME;

EID: 84938742821     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.13056     Document Type: Article

References (37)

1. Coeytaux A, Jallon P, Galobardes B,. Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR). Neurology 2000; 55: 693-697.
2. Knake S, Rosenow F, Vescovi M, et al., Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia 2001; 42: 714-718.
3. Wu YW, Shek DW, Garcia PA, et al., Incidence and mortality of generalized convulsive status epilepticus in California. Neurology 2002; 58: 1070-1076.
4. Vignatelli L, Tonon C, D'Alessandro R,. Incidence and short-term prognosis of status epilepticus in adults in Bologna, Italy. Epilepsia 2003; 44: 964-968.
5. Brophy GM, Bell R, Claassen J, et al., Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012; 17: 3-23.
6. Meierkord H, Boon P, Engelsen B, et al., EFNS guideline on the management of status epilepticus in adults. Eur J Neurol 2010; 17: 348-355.
7. Cook AM, Castle A, Green A, et al., Practice variations in the management of status epilepticus. Neurocrit Care 2012; 17: 24-30.
8. Treiman DM, Meyers PD, Walton NY, et al., A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998; 339: 792-798.
9. Alldredge BK, Gelb AM, Isaacs M, et al., A comparison of lorazepam, diazepam, and placebo for the treatement of out-of-hospital status epilepticus. N Engl J Med 2001; 345: 631-637.
10. Silbergleit R, Durkalski V, Lowenstein D, et al., Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med 2012; 366: 591-600.
11. Shorvon S, Baulac M, Cross H, et al., The drug treatment of status epilepticus in Europe: consensus document from a workshop at the first London Colloquium on Status Epilepticus. Epilepsia 2008; 49: 1277-1288.
12. Riss J, Cloyd J, Gates J, et al., Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand 2008; 118: 69-86.
13. Browne TR,. Clonazepam: a review of a new anticonvulsant drug. Arch Neurol 1976; 33: 326-332.
14. Crevoisier C, Delisle MC, Joseph I, et al., Comparative single-dose pharmacokinetics of clonazepam following intravenous, intramuscular and oral administration to healthy volunteers. Eur Neurol 2003; 49: 173-177.
15. Bauer TM, Ritz R, Haberthür C, et al., Prolonged sedation due to accumulation of conjugated metabolites of midazolam. Lancet 1995; 346: 145-147.
16. Alvarez V, Januel J-M, Burnand B, et al., Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam. Epilepsia 2011; 52: 1292-1296.
17. Alvarez V, Januel J-M, Burnand B, et al., Role of comorbidities in outcome prediction after status epilepticus. Epilepsia 2012; 53: e89-e92.
18. Rossetti AO, Alvarez V, Burnand B, et al., Treatment deviating from guidelines does not influence status epilepticus prognosis. J Neurol 2013; 260: 421-428.
19. Beniczky S, Hirsch LJ, Kaplan PW, et al., Unified EEG terminology and criteria for nonconvulsive status epilepticus. Epilepsia 2013; 54 (Suppl. 6): 28-29.
20. Rossetti AO, Bleck TP,. What's new in status epilepticus? Intensive Care Med 2014; 40: 1359-1362.
21. Berg A, Berkovic SF, Brodie M, et al., Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010; 51: 676-685.
22. Rossetti AO, Hurwitz S, Logroscino G, et al., Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation. J Neurol Neurosurg Psychiatry 2006; 77: 611-615.
23. Rossetti AO, Logroscino G, Milligan TA, et al., Status Epilepticus Severity Score (STESS): a tool to orient early treatment strategy. J Neurol 2008; 255: 1561-1566.
24. Rossetti AO, Lowenstein DH,. Management of refractory status epilepticus in adults: still more questions than answers. Lancet Neurol 2011; 10: 922-930.
25. Tsai M-H, Chuang Y-C, Chang H-W, et al., Factors predictive of outcome in patients with de novo status epilepticus. Q J Med 2009; 102: 57-62.
26. Leppik IE, Derivan AT, Homan RW, et al., Double-blind study of lorazepam and diazepam in status epilepticus. JAMA 1983; 249: 1452-1454.
27. Sorel L, Mechler L, Harmant J,. Comparative trial of intravenous lorazepam and clonazepam im status epilepticus. Clin Ther 1981; 4: 326-336.
28. Congdon PJ, Forsythe WI,. Intravenous clonazepam in the treatment of status epilepticus in children. Epilepsia 1980; 21: 97-102.
29. Rantsch K, Walter U, Wittstock M, et al., Treatment and course of different subtypes of status epilepticus. Epilepsy Res 2013; 107: 156-162.
30. Treiman DM,. Pharmacokinetics and clinical use of benzodiazepines in the management of status epilepticus. Epilepsia 1989; 30 (Suppl. 2): S4-S10.
31. Singh AN, Le Morvan P,. Treatment of status epilepticus with intravenous clonazepam. Prog Neuropsychopharmacol Biol Psychiatry 1982; 8: 539-542.
32. Towne AR, Pellock JM, Ko D, et al., Determinants of mortality in status epilepticus. Epilepsia 1994; 35: 27-34.
33. Logroscino G, Hesdorffer DC, Cascino G, et al., Short-term mortality after a first episode of status epilepticus. Epilepsia 1997; 38: 1344-1349.
34. Drislane FW, Blum AS, Lopez MR, et al., Duration of refractory status epilepticus and outcome: loss of prognostic utility after several hours. Epilepsia 2009; 50: 1566-1571.
35. Sutter R, Kaplan PW, Rüegg S,. Outcome predictors for status epilepticus-what really counts. Nat Rev Neurol 2013; 9: 525-534.
36. Aranda A, Foucart G, Ducassé JL, et al., Generalized convulsive status epilepticus management in adults: a cohort study with evaluation of professional practice. Epilepsia 2010; 51: 2159-2167.
37. Cascino GD, Hesdorffer D, Logroscino G, et al., Treatment of nonfebrile status epilepticus in Rochester, Minn, from 1965 through 1984. Mayo Clin Proc 2001; 76: 39-41.